Supplemental oxygen to improve the efficiency of exercise training therapy in type 2 diabetes patients.
Recruiting
- Conditions
- Diabetes mellitus type 2
- Registration Number
- NL-OMON21976
- Lead Sponsor
- Erasmus MCP.O.Box 2040, NL-3000 CA Rotterdamphone: +31 10 703 18 87 / 31 80 (secr)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 36
Inclusion Criteria
1. Type 2 diabetes according to WHO criteria for over 2 years;
2. VO2peak 60-90% of age-predicted value as measured on a cycle-ergometer;
Exclusion Criteria
1. Use of ß-blocker therapy;
2. Exogenous insulin therapy (for substudy 2 only);
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main study parameters/endpoints: The main study parameter and end-point is the relative improvement in whole-body insulin sensitivity.
- Secondary Outcome Measures
Name Time Method Secondary end-points are relative improvements in vascular function parameters using forearm plethysmography, cardiovascular fitness, systemic blood pressure, body composition, lipid metabolism and glycemic control.<br>